SciELO - Scientific Electronic Library Online

 
vol.32 issue6Awareness and implementation in daily practice of the S.E.N.-semFYC consensus document on chronic kidney diseaseAcute renal failure predictors in elderly patients with chronic kidney disease author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nefrología (Madrid)

On-line version ISSN 1989-2284Print version ISSN 0211-6995

Abstract

FLORES-SOLIS, Larry M.; HERNANDEZ-DOMINGUEZ, Juan L.; OTERO-GONZALEZ, Alfonso  and  GONZALEZ-JUANATEY, José R.. Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure. Nefrología (Madr.) [online]. 2012, vol.32, n.6, pp.809-818. ISSN 1989-2284.  https://dx.doi.org/10.3265/Nefrologia.pre2012.Jul.10986.

Objective: The aim of our study was to evaluate cut-off values for acute the cardiac biomarkers cardiac troponin I (cTnI) and creatine kinase MB isoenzyme (CK-MB) in patients with chronic renal failure (CRF) different to the cut-off values proposed by the manufacturers and frequently used at the laboratory. Method: We performed a prospective study in patients with CRF with a glomerular filtration rate estimated by the MDRD-4 equation <60mL/min admitted with suspected acute coronary syndrome (ACS) by history, physical examination, and electrocardiography. cTnI and CK-MB measurements were assessed at admission and six months later by using two different analytical methods (for cTnI: Access® and Vidas® analysers, and for CK-MB: Access® and Vitros® analysers). Results: During the study period, 484 patients with CRF and suspected ACS were included. ACS was diagnosed in 12% of patients (58/484), while we finded other cardiac pathologies (OCP) in 29% of patients (140/484) and other non-cardiac pathologies (ONCP) in 59% of patients (286/484). For cTnI of the Access® analyser with the usual cut-off value (≥0.5ng/mL), the sensitivity was 43% and specificity was 94%, while for the proposed cut-off value (≥0.11ng/mL), the values were 68% and 83%, respectively. For cTnI assessed using the Vidas® analyser with the usual cut-off value (≥0.11ng/mL), sensitivity was 64% and specificity was 87%, while for the proposed cut-off value (≥0.06ng/mL), the values were 75% and 79%, respectively. The sensitivity and specificity for both CK-MB were lower compared with cTnI. Conclusion: The cut-off values proposed in this study for both cTnI in patients with CRF (stage 3 to 5) to diagnose ACS are significantly different from that of the general population.

Keywords : Cardiac troponin I; Creatine kinase MB; Chronic renal failure.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License